# IGC Pharma, Inc.: Form DEF 14A, filed Dec 8, 2020

- Company: [IGC Pharma, Inc.](/companies/igc.md) (CIK 1326205)
- Form: DEF 14A
- Filed: 2020-12-08
- Accepted by EDGAR: Dec 8, 2020, 16:16 ET
- Period: 2021-01-11
- Accession: 0001185185-20-001724
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1326205/000118518520001724/indiaglob20201204_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326205/000118518520001724/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326205/000118518520001724/indiaglob20201204_def14a.htm

Filed Dec 8, 2020.
Source: SEC EDGAR, the filing index for accession 0001185185-20-001724. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.
